Rheumatology | European Federation of Internal Medicine

Rheumatology (Greek ρεύμα, rheuma, river) is a sub-specialty in internal medicine and pediatrics, devoted to diagnosis and therapyof rheumatic diseases. Clinicians who specialize in rheumatology are called rheumatologists. Rheumatologists deal mainly with clinical problems involving joints, soft tissues, autoimmune diseases, vasculitis, and heritable connective tissue disorders.

ACR: Investigational lupus drugs test new or reworked approaches to treatment

Posted on: 19/11/2015 - 20:39

SAN FRANCISCO – A variety of new, repurposed, and reformulated compounds have made their way into clinical trials for systemic lupus erythematosus, as evidenced by an abstracts session devoted to...

Field of Interest: Rheumatology

Type: News Item

ACR: Criteria enable prompt diagnosis and treatment of CAPS

Posted on: 19/11/2015 - 17:37

SAN FRANCISCO – Valid diagnostic criteria for cryopyrin-associated periodic syndromes are sorely needed, and a new model of CAPS diagnostic criteria enables rapid diagnosis of this rare,...

Field of Interest: Rheumatology

Type: News Item

ACR: Adalimumab best TNFi for anterior uveitis in ankylosing spondylitis

Posted on: 19/11/2015 - 17:21

SAN FRANCISCO – Adalimumab was the clear winner over infliximab and etanercept for anterior uveitis in a Scandinavian database study of 1,365 patients with ankylosing spondylitis. Office visits for...

Field of Interest: Rheumatology

Type: News Item

Riociguat deemed suitable for PAH in connective tissue disease

Posted on: 18/11/2015 - 20:50

SAN FRANCISCO – Phase III clinical trial experience in using riociguat indicates that the drug is just as safe and effective in treating pulmonary arterial hypertension associated with connective...

Field of Interest: Rheumatology

Type: News Item

Triple therapy less effective than combination therapy for rheumatoid arthritis

Posted on: 18/11/2015 - 20:06

SAN FRANCISCO – Triple therapy for rheumatoid arthritis using methotrexate, sulfasalazine, and hydroxychloroquine is less effective than the combination of tumor necrosis factor inhibitor and...

Field of Interest: Rheumatology

Type: News Item

Real-world use of triple therapy for RA differs from clinical trial use

Posted on: 18/11/2015 - 19:33

SAN FRANCISCO – Triple therapy for rheumatoid arthritis has shone in clinical trials, but its adoption by rheumatologists in the trenches of patient care has been lukewarm. The challenges facing...

Field of Interest: Rheumatology

Type: News Item

Targeting IL-6 effective in RA poor responders to anti-TNF inhibitors

Posted on: 18/11/2015 - 19:22

SAN FRANCISCO – Sarilumab, an investigational monoclonal antibody directed against the IL-6 receptor, demonstrated efficacy at two different dose levels, compared with placebo, in patients with...

Field of Interest: Rheumatology

Type: News Item

Baricitinib shows encouraging phase III results in RA

Posted on: 18/11/2015 - 13:54

SAN FRANCISCO – Baricitinib, an investigational oral investigational JAK 1/2 inhibitor, was significantly superior to adalimumab and to placebo in the treatment of patients with active rheumatoid...

Field of Interest: Rheumatology

Type: News Item

Multibiomarker blood test could aid treatment decisions in RA

Posted on: 17/11/2015 - 23:07

SAN FRANCISCO – Vectra DA, a multibiomarker blood test, can predict response to therapy for patients with rheumatoid arthritis, and it can also identify patients who can safely taper and...

Field of Interest: Rheumatology

Type: News Item

ACR: Mycophenolate reduces need for GAVE endoscopy

Posted on: 17/11/2015 - 19:07

SAN FRANCISCO – Mycophenolate significantly reduces the need for endoscopic interventions for gastric antral vascular ectasia in patients with systemic sclerosis, according to investigators...

Field of Interest: Rheumatology

Type: News Item

« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »

Newsletters

Stay informed on our latest news!

Latest Newsletters